Intractable & Rare Diseases Research

metrics 2024

Pioneering Research in Rare Disease Solutions.

Introduction

Intractable & Rare Diseases Research is a pioneering journal dedicated to advancing the understanding and treatment of rare and intractable diseases. Published by INT RESEARCH & COOPERATION ASSOC BIO & SOCIO-SCIENCES ADVANCEMENT in Japan, this esteemed journal serves as a critical platform for researchers, clinicians, and healthcare professionals to share groundbreaking findings and developments in the field. With its established Scopus ranking of #238 out of 636 in the General Medicine category, placing it in the 62nd percentile, and its classification in the Q3 quartile for 2023, it is recognized as a significant contributor to the literature on rare diseases. Operating without an open-access model, the journal ensures high-quality content cultivated through rigorous peer-review processes. Through its scope spanning from 2012 to 2024, the journal aspires to bridge gaps in knowledge and foster collaboration among interdisciplinary researchers, ultimately aiming to improve patient outcomes and enhance public health concerning these challenging conditions.

Metrics 2024

SCIMAGO Journal Rank0.32
Journal Impact Factor1.10
Journal Impact Factor (5 years)1.50
H-Index31
Journal IF Without Self1.10
Eigen Factor0.00
Normal Eigen Factor0.16
Influence0.36
Immediacy Index0.40
Cited Half Life6.00
Citing Half Life7.20
JCI0.25
Total Documents490
WOS Total Citations742
SCIMAGO Total Citations1983
SCIMAGO SELF Citations62
Scopus Journal Rank0.32
Cites / Document (2 Years)1.12
Cites / Document (3 Years)1.31
Cites / Document (4 Years)1.29

Metrics History

Rank 2024

Scopus

General Medicine in Medicine
Rank #238/636
Percentile 62.58
Quartile Q2

IF (Web Of Science)

MEDICINE, GENERAL & INTERNAL
Rank 161/325
Percentile 50.60
Quartile Q2

JCI (Web Of Science)

MEDICINE, GENERAL & INTERNAL
Rank 182/329
Percentile 44.68
Quartile Q3

Quartile History

Similar Journals

IDCases

Driving collaboration for global health solutions.
Publisher: ELSEVIER SCI LTDISSN: 2214-2509Frequency: 1 issue/year

Welcome to IDCases, a peer-reviewed open access journal published by Elsevier Science Ltd that has been at the forefront of infectious disease research since 2014. With a ISSN of 2214-2509, IDCases is dedicated to the publication of high-quality case reports and novel findings in the field of infectious diseases, aiming to enhance clinical practice and guide therapeutic decision-making. Positioned in the Q3 Quartile of the infectious diseases category, and ranked #213 out of 344 in Scopus’s Medicine _ Infectious Diseases category, the journal establishes essential connections between academia and the healthcare community. As an open access journal, IDCases ensures that critical research is disseminated widely, fostering collaboration and innovation in managing infectious diseases. By encouraging submissions that explore both common and rare infections, global outbreaks, and novel therapeutic approaches, IDCases serves as a critical resource for researchers, healthcare professionals, and students alike. Join us in advancing the discourse and understanding of infectious diseases!

Biomedical Reports

Exploring the frontiers of biochemistry and genetics.
Publisher: SPANDIDOS PUBL LTDISSN: 2049-9434Frequency: 6 issues/year

Biomedical Reports, published by SPANDIDOS PUBL LTD in Greece, is a distinguished open-access journal that focuses on the dynamic fields of biochemistry, genetics, molecular biology, medicine, pharmacology, and neuroscience. Established in 2014, the journal has rapidly gained recognition, securing Q2 and Q3 rankings in several categories for 2023, including a notable ranking of #125/636 in General Medicine, placing it in the 80th percentile amongst its peers. The journal continually aims to disseminate innovative research findings that advance the understanding of complex biomedical issues, making it an invaluable resource for researchers, professionals, and students alike. Its multidisciplinary approach not only reflects the interconnectivity of modern biomedical sciences but also promotes collaborative discourse among diverse fields, ensuring ongoing relevance and impact within the scientific community.

Journal of Pediatric Infectious Diseases

Fostering knowledge for a healthier future in pediatrics.
Publisher: GEORG THIEME VERLAG KGISSN: 1305-7707Frequency: 4 issues/year

Journal of Pediatric Infectious Diseases, published by GEORG THIEME VERLAG KG, serves as a vital platform for the dissemination of cutting-edge research in the fields of pediatric infectious diseases and related areas. With an ISSN of 1305-7707 and an E-ISSN of 1305-7693, this journal endeavors to address critical issues and innovations in pediatric medicine, fostering an understanding of infectious diseases that affect children. The journal is indexed in Scopus, where it holds a Q4 ranking in both Infectious Diseases and Pediatrics, Perinatology and Child Health, reflecting its emerging status within medical research. Although currently not open access, it offers valuable insights and empirical research crucial for healthcare professionals, researchers, and students dedicated to improving pediatric care. The Journal of Pediatric Infectious Diseases not only highlights contemporary challenges faced by pediatric health practitioners but also aims to be a cornerstone for future developments in the management and prevention of infections in young populations.

Boletin de Pediatria

Exploring New Frontiers in Pediatric Healthcare
Publisher: EDICIONES ERGON SAISSN: 0214-2597Frequency: 4 issues/year

Boletin de Pediatria is a distinguished journal dedicated to the field of pediatric medicine, serving as a valuable resource for researchers, clinicians, and students alike. Published by EDICIONES ERGON SA, this journal is committed to advancing the knowledge and practice of pediatric healthcare. With its ISSN 0214-2597 and E-ISSN 2340-5384, it strives to disseminate high-quality, peer-reviewed research that addresses the latest advancements and best practices in pediatrics. Although specific impact factor data is not currently available, the journal's rigorous publication standards maintain its reputation within the scientific community. Notably, while Boletin de Pediatria is not an open-access journal, it provides digital access options that ensure the wide distribution of critical pediatric research. With a commitment to improving child health outcomes, this journal plays an essential role in fostering innovation and collaboration among pediatric healthcare professionals globally.

Case Reports in Immunology

Advancing Immunology One Case Report at a Time
Publisher: HINDAWI LTDISSN: 2090-6609Frequency:

Case Reports in Immunology, published by HINDAWI LTD, is an esteemed open-access journal that has been contributing to the field of immunology since its launch in 2011. With both ISSN 2090-6609 and E-ISSN 2090-6617, the journal provides a platform for researchers to publish detailed case reports that explore diverse immunological conditions and novel treatment approaches. This journal is crucial for clinicians, researchers, and students alike, seeking to broaden their understanding of immunology's practical applications and advances. As of 2023, it holds a Q3 ranking in Immunology and Q2 in Immunology and Allergy, reflecting its growing relevance and contribution to the field. Additionally, it is indexed in Scopus, where it ranks #178 in Immunology and Allergy and #192 in Immunology and Microbiology, enhancing its visibility and impact. With a comprehensive accessibility model, the journal is dedicated to disseminating knowledge widely and enriching discussions in immunological research.

Journal of Cardiovascular Translational Research

Unveiling Breakthroughs in Cardiovascular Research and Treatment
Publisher: SPRINGERISSN: 1937-5387Frequency: 6 issues/year

Journal of Cardiovascular Translational Research, published by Springer, is a pivotal platform in the fields of cardiology, genetics, and molecular medicine, dedicated to bridging the gap between experimental research and clinical application. With an impressive impact factor and a robust ranking—such as Rank #84/387 in Cardiology and Cardiovascular Medicine—this journal offers valuable insights and innovative research vital for understanding cardiovascular diseases and their implications. The journal spans a unique converged spectrum of topics, encompassing pharmaceutical sciences and genetic advancements, making it an essential resource for researchers, healthcare professionals, and students alike, striving for excellence in cardiovascular health. Although not open access, the journal ensures that cutting-edge research from 2008 to 2024 is readily available for a diverse readership eager to harness knowledge for clinical progress and improved patient outcomes.

Nature Reviews Disease Primers

Navigating the Complexities of Health and Disease
Publisher: NATURE PORTFOLIOISSN: 2056-676XFrequency: 1 issue/year

Nature Reviews Disease Primers, published by NATURE PORTFOLIO, stands as a leading journal in the field of Medicine, specifically recognized for its comprehensive coverage of various diseases and health-related topics. With an impressive impact factor that reflects its high citation rate, this journal is categorized within the Q1 quartile in Medicine (miscellaneous) and holds a prestigious Scopus rank of #4 out of 636, placing it in the 99th percentile of general medicine publications. Launched in 2015 and projected to continue its influence until 2024, the journal aims to bridge the gap between clinical research and practical application, providing easy-to-digest primers that summarize current understanding and emerging trends in various diseases. While not classified as open access, its rigorously peer-reviewed content remains crucial for academic researchers, healthcare professionals, and students alike, striving to stay at the forefront of medical knowledge. The journal's base in the United Kingdom enhances its global reach, contributing to the ongoing dialogue in the medical community.

Case Reports in Infectious Diseases

Advancing knowledge through unique case insights.
Publisher: HINDAWI LTDISSN: 2090-6625Frequency: 1 issue/year

Case Reports in Infectious Diseases is a premier open-access journal published by Hindawi Ltd, dedicated to advancing the field of infectious disease research through the dissemination of case reports that highlight unique clinical presentations, innovative treatment approaches, and novel diagnostic techniques. Since its inception in 2011, this journal has provided a vital platform for healthcare professionals, academicians, and researchers to share their findings, thereby enhancing the collective understanding of infectious diseases. Featuring a diverse range of case studies, the journal aims to inspire further research and clinical inquiry, making it an invaluable resource for anyone involved in the fight against infectious diseases. With an easily accessible online format, it caters to a global audience, ensuring that critical insights are available to all stakeholders in this crucial field.

Case Reports in Oncological Medicine

Advancing oncology through shared clinical insights.
Publisher: HINDAWI LTDISSN: 2090-6706Frequency: 1 issue/year

Case Reports in Oncological Medicine is a distinguished open-access journal published by HINDAWI LTD, dedicated to disseminating valuable insights and findings in the field of oncology. Since its inception in 2011, this journal has aimed to provide a unique platform for the publication of detailed case reports that contribute to our understanding of cancer diagnosis, treatment, and management. With a specific focus on sharing clinical experiences and outcomes, it seeks to engage researchers, healthcare professionals, and students who are committed to advancing oncological knowledge and improving patient care. Although coverage in Scopus was discontinued from 2014 to 2017, the journal currently holds a rank of #232/323 in Medicine - Oncology, placing it within the 28th percentile. Researchers interested in making their work accessible can benefit from the journal's open-access model, allowing greater visibility and citation potential within the scientific community. The journal is positioned as an important resource for those looking to stay updated on the latest case studies and innovations in oncological medicine.

KEIO JOURNAL OF MEDICINE

Connecting Researchers to Transform Medical Practice
Publisher: KEIO JOURNAL MEDICINEISSN: 0022-9717Frequency: 4 issues/year

KEIO JOURNAL OF MEDICINE, published by the Keio University in Japan, is an esteemed medical journal that has been a cornerstone of medical research since its inception in 1952. With an ISSN of 0022-9717 and an E-ISSN of 1880-1293, this journal plays a crucial role in disseminating valuable research across various disciplines within the field of medicine. Currently ranking in the Q3 quartile in the category of Medicine (miscellaneous) and holding a commendable Scopus Ranks of #168 out of 636 publishers, it stands in the 73rd percentile, highlighting its growing impact in the academic community. The journal's commitment to enhancing medical knowledge is evident through its rigorous peer-review process, aiming to provide high-quality content that appeals to researchers, practitioners, and students alike. Although the journal operates under a subscription model, it remains a vital resource for those invested in advancing the field of medicine, addressing contemporary challenges, and exploring innovations in medical practice.